About this document

Vonoprazan: A Novel P-CAB Overview by mayurimandlekar1 is a document available to read on EtoBox.

Vonoprazan is a novel potassium-competitive acid blocker (P-CAB) that offers faster onset and more consistent effects compared to traditional PPIs, making it effective for treating gastric acid-related diseases such as GERD, ulcers, and H. pylori. It works independently of food and CYP2C19 variability, with a favorable pharmacokinetic profile allowing for once-daily dosing. Clinical trials demonstrate its superior efficacy in healing erosive esophagitis and eradicating H. pylori compared to lansoprazole.

Author

mayurimandlekar1

Language

EN